CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


CA Cancer J Clin 1996; 46:261
doi: 10.3322/canjclin.46.5.261
© 1996 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gagel, R. F.
Right arrow Articles by Callender, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gagel, R. F.
Right arrow Articles by Callender, D. L.

CA: A Cancer Journal for Clinicians, Vol 46, Issue 5 261-283, Copyright © 1996 by American Cancer Society


ARTICLES

Changing concepts in the pathogenesis and management of thyroid carcinoma

R. F. Gagel, H. Goepfert and D. L. Callender
Endocrine Neoplasia and Hormonal Disorders, University of Texas M. D. Anderson Cancer Center, Houston, USA.

A wealth of knowledge regarding the molecular causation of thyroid carcinoma has been accumulated over the past five years. This information has already had a significant impact on the management of some forms of thyroid carcinoma. The challenge during the next 10 years will be to incorporate newly acquired information into diagnostic and therapeutic approaches to thyroid carcinoma and to coordinate use of this information with time-tested approaches to further decrease morbidity and mortality from thyroid carcinoma.


This article has been cited by other articles:


Home page
Arch Otolaryngol Head Neck SurgHome page
K. L. Wirfel, M. L. Richards, and R. A. Otto
Papillary Cancer of the Thyroid in Low-Risk Patients: The Perspective of the University of Texas Health Science Center at San Antonio
Arch Otolaryngol Head Neck Surg, April 1, 2001; 127(4): 458 - 461.
[Full Text] [PDF]


Home page
Arch SurgHome page
L. E. Sanders and B. Cady
Differentiated Thyroid Cancer: Reexamination of Risk Groups and Outcome of Treatment
Arch Surg, April 1, 1998; 133(4): 419 - 425.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K.-C. Loh, F. S. Greenspan, L. Gee, T. R. Miller, and P. P. B. Yeo
Pathological Tumor-Node-Metastasis (pTNM) Staging for Papillary and Follicular Thyroid Carcinomas: A Retrospective Analysis of 700 Patients
J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3553 - 3562.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by American Cancer Society.